% alzhub.org library filter
% Source: https://alzhub.org/research?author=Sabbagh+MN
% 26 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{honig2024-38730496,
  author  = {Honig, L. S. and Sabbagh, M. N. and van Dyck, C. H. and Sperling, R. A. and Hersch, S. and Matta, A. and Giorgi, L. and Gee, M. and others},
  title   = {{Updated safety results from phase 3 lecanemab study in early Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01441-8},
  pmid    = {38730496},
  url     = {https://doi.org/10.1186/s13195-024-01441-8}
}

@article{salloway2018-29914022,
  author  = {Salloway, S. P. and Sperling, R. and Fox, N. C. and Sabbagh, M. N. and Honig, L. S. and Porsteinsson, A. P. and Rofael, H. and Ketter, N. and others},
  title   = {{Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2018},
  doi     = {10.3233/jad-171157},
  pmid    = {29914022},
  url     = {https://doi.org/10.3233/jad-171157}
}

@article{rafii2022-35532913,
  author  = {Rafii, M. S. and Sol, O. and Mobley, W. C. and Delpretti, S. and Skotko, B. G. and Burke, A. D. and Sabbagh, M. N. and Yuan, S. H. and others},
  title   = {{Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.0983},
  pmid    = {35532913},
  url     = {https://doi.org/10.1001/jamaneurol.2022.0983}
}

@article{curtis2015-25622185,
  author  = {Curtis, C. and Gamez, J. E. and Singh, U. and Sadowsky, C. H. and Villena, T. and Sabbagh, M. N. and Beach, T. G. and Duara, R. and others},
  title   = {{Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2014.4144},
  pmid    = {25622185},
  url     = {https://doi.org/10.1001/jamaneurol.2014.4144}
}

@article{caselli2009-19605830,
  author  = {Caselli, R. J. and Dueck, A. C. and Osborne, D. and Sabbagh, M. N. and Connor, D. J. and Ahern, G. L. and Baxter, L. C. and Rapcsak, S. Z. and others},
  title   = {{Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect}},
  journal = {The New England journal of medicine},
  year    = {2009},
  doi     = {10.1056/nejmoa0809437},
  pmid    = {19605830},
  url     = {https://doi.org/10.1056/nejmoa0809437}
}

@article{galasko2014-24696507,
  author  = {Galasko, D. and Bell, J. and Mancuso, J. Y. and Kupiec, J. W. and Sabbagh, M. N. and van Dyck, C. and Thomas, R. G. and Aisen, P. S. and others},
  title   = {{Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease}},
  journal = {Neurology},
  year    = {2014},
  doi     = {10.1212/wnl.0000000000000364},
  pmid    = {24696507},
  url     = {https://doi.org/10.1212/wnl.0000000000000364}
}

@article{sabbagh2011-21192237,
  author  = {Sabbagh, M. N. and Agro, A. and Bell, J. and Aisen, P. S. and Schweizer, E. and Galasko, D.},
  title   = {{PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2011},
  doi     = {10.1097/wad.0b013e318204b550},
  pmid    = {21192237},
  url     = {https://doi.org/10.1097/wad.0b013e318204b550}
}

@article{doraiswamy2012-22786606,
  author  = {Doraiswamy, P. M. and Sperling, R. A. and Coleman, R. E. and Johnson, K. A. and Reiman, E. M. and Davis, M. D. and Grundman, M. and Sabbagh, M. N. and others},
  title   = {{Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study}},
  journal = {Neurology},
  year    = {2012},
  doi     = {10.1212/wnl.0b013e3182661f74},
  pmid    = {22786606},
  url     = {https://doi.org/10.1212/wnl.0b013e3182661f74}
}

@article{sparks2005-15883262,
  author  = {Sparks, D. L. and Sabbagh, M. N. and Connor, D. J. and Lopez, J. and Launer, L. J. and Browne, P. and Wasser, D. and Johnson-Traver, S. and others},
  title   = {{Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results}},
  journal = {Archives of neurology},
  year    = {2005},
  doi     = {10.1001/archneur.62.5.753},
  pmid    = {15883262},
  url     = {https://doi.org/10.1001/archneur.62.5.753}
}

@article{johnson2013-23375563,
  author  = {Johnson, K. A. and Sperling, R. A. and Gidicsin, C. M. and Carmasin, J. S. and Maye, J. E. and Coleman, R. E. and Reiman, E. M. and Sabbagh, M. N. and others},
  title   = {{Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2013},
  doi     = {10.1016/j.jalz.2012.10.007},
  pmid    = {23375563},
  url     = {https://doi.org/10.1016/j.jalz.2012.10.007}
}

@article{sparks2006-16866904,
  author  = {Sparks, D. L. and Connor, D. J. and Sabbagh, M. N. and Petersen, R. B. and Lopez, J. and Browne, P.},
  title   = {{Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial}},
  journal = {Acta neurologica Scandinavica. Supplementum},
  year    = {2006},
  doi     = {10.1111/j.1600-0404.2006.00690.x},
  pmid    = {16866904},
  url     = {https://doi.org/10.1111/j.1600-0404.2006.00690.x}
}

@article{sabbagh2023-37695107,
  author  = {Sabbagh, M. N. and Mathew, P. and Blau, A.},
  title   = {{A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2023},
  doi     = {10.1097/wad.0000000000000578},
  pmid    = {37695107},
  url     = {https://doi.org/10.1097/wad.0000000000000578}
}

@article{porsteinsson2021-34101796,
  author  = {Porsteinsson, A. P. and Isaacson, R. S. and Knox, S. and Sabbagh, M. N. and Rubino, I.},
  title   = {{Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2021},
  doi     = {10.14283/jpad.2021.23},
  pmid    = {34101796},
  url     = {https://doi.org/10.14283/jpad.2021.23}
}

@article{sparks2005-15974900,
  author  = {Sparks, D. L. and Sabbagh, M. N. and Connor, D. J. and Lopez, J. and Launer, L. J. and Petanceska, S. and Browne, P. and Wassar, D. and others},
  title   = {{Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD}},
  journal = {Current Alzheimer research},
  year    = {2005},
  doi     = {10.2174/1567205054367900},
  pmid    = {15974900},
  url     = {https://doi.org/10.2174/1567205054367900}
}

@article{damian2011-21282950,
  author  = {Damian, A. M. and Jacobson, S. A. and Hentz, J. G. and Belden, C. M. and Shill, H. A. and Sabbagh, M. N. and Caviness, J. N. and Adler, C. H.},
  title   = {{The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scores}},
  journal = {Dementia and geriatric cognitive disorders},
  year    = {2011},
  doi     = {10.1159/000323867},
  pmid    = {21282950},
  url     = {https://doi.org/10.1159/000323867}
}

@article{doraiswamy2014-24614494,
  author  = {Doraiswamy, P. M. and Sperling, R. A. and Johnson, K. and Reiman, E. M. and Wong, T. Z. and Sabbagh, M. N. and Sadowsky, C. H. and Fleisher, A. S. and others},
  title   = {{Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study}},
  journal = {Molecular psychiatry},
  year    = {2014},
  doi     = {10.1038/mp.2014.9},
  pmid    = {24614494},
  url     = {https://doi.org/10.1038/mp.2014.9}
}

@article{sparks2002-12474023,
  author  = {Sparks, D. L. and Connor, D. J. and Browne, P. J. and Lopez, J. E. and Sabbagh, M. N.},
  title   = {{HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier}},
  journal = {The journal of nutrition, health \& aging},
  year    = {2002},
  pmid    = {12474023}
}

@article{yin2020-32457210,
  author  = {Yin, J. and Reiman, E. M. and Beach, T. G. and Serrano, G. E. and Sabbagh, M. N. and Nielsen, M. and Caselli, R. J. and Shi, J.},
  title   = {{Effect of ApoE isoforms on mitochondria in Alzheimer disease}},
  journal = {Neurology},
  year    = {2020},
  doi     = {10.1212/wnl.0000000000009582},
  pmid    = {32457210},
  url     = {https://doi.org/10.1212/wnl.0000000000009582}
}

@article{caviness2007-17415797,
  author  = {Caviness, J. N. and Driver-Dunckley, E. and Connor, D. J. and Sabbagh, M. N. and Hentz, J. G. and Noble, B. and Evidente, V. G. and Shill, H. A. and others},
  title   = {{Defining mild cognitive impairment in Parkinson's disease}},
  journal = {Movement disorders : official journal of the Movement Disorder Society},
  year    = {2007},
  doi     = {10.1002/mds.21453},
  pmid    = {17415797},
  url     = {https://doi.org/10.1002/mds.21453}
}

@article{caviness2015-25420672,
  author  = {Caviness, J. N. and Hentz, J. G. and Belden, C. M. and Shill, H. A. and Driver-Dunckley, E. D. and Sabbagh, M. N. and Powell, J. J. and Adler, C. H.},
  title   = {{Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson's disease}},
  journal = {Journal of Parkinson's disease},
  year    = {2015},
  doi     = {10.3233/jpd-140480},
  pmid    = {25420672},
  url     = {https://doi.org/10.3233/jpd-140480}
}

@article{vitek2023-36749830,
  author  = {Vitek, G. E. and Decourt, B. and Sabbagh, M. N.},
  title   = {{Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease}},
  journal = {Expert opinion on investigational drugs},
  year    = {2023},
  doi     = {10.1080/13543784.2023.2178414},
  pmid    = {36749830},
  url     = {https://doi.org/10.1080/13543784.2023.2178414}
}

@article{sabbagh2020-32463070,
  author  = {Sabbagh, M. N. and Boada, M. and Borson, S. and Doraiswamy, P. M. and Dubois, B. and Ingram, J. and Iwata, A. and Porsteinsson, A. P. and others},
  title   = {{Early Detection of Mild Cognitive Impairment (MCI) in an At-Home Setting}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2020},
  doi     = {10.14283/jpad.2020.22},
  pmid    = {32463070},
  url     = {https://doi.org/10.14283/jpad.2020.22}
}

@article{decourt2022-36339394,
  author  = {Decourt, B. and Noorda, K. and Shi, J. and Sabbagh, M. N.},
  title   = {{Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat Dementia}},
  journal = {Journal of experimental pharmacology},
  year    = {2022},
  doi     = {10.2147/jep.s265626},
  pmid    = {36339394},
  url     = {https://doi.org/10.2147/jep.s265626}
}

@article{sabbagh2011-22084131,
  author  = {Sabbagh, M. N. and Fleisher, A. and Chen, K. and Rogers, J. and Berk, C. and Reiman, E. and Pontecorvo, M. and Mintun, M. and others},
  title   = {{Positron emission tomography and neuropathologic estimates of fibrillar amyloid-β in a patient with Down syndrome and Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2011},
  doi     = {10.1001/archneurol.2011.535},
  pmid    = {22084131},
  url     = {https://doi.org/10.1001/archneurol.2011.535}
}

@article{shill2008-18413570,
  author  = {Shill, H. A. and Adler, C. H. and Sabbagh, M. N. and Connor, D. J. and Caviness, J. N. and Hentz, J. G. and Beach, T. G.},
  title   = {{Pathologic findings in prospectively ascertained essential tremor subjects}},
  journal = {Neurology},
  year    = {2008},
  doi     = {10.1212/01.wnl.0000310425.76205.02},
  pmid    = {18413570},
  url     = {https://doi.org/10.1212/01.wnl.0000310425.76205.02}
}

@article{arab2010-20182018,
  author  = {Arab, L. and Sabbagh, M. N.},
  title   = {{Are certain lifestyle habits associated with lower Alzheimer's disease risk?}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2010},
  doi     = {10.3233/jad-2010-091573},
  pmid    = {20182018},
  url     = {https://doi.org/10.3233/jad-2010-091573}
}